Access to vaccination against COVID-19 is a public health priority and essential for each patient concerned. To best protect immunocompromised people, vaccinating their family and friends and respecting barrier measures remain the best ways to avoid contamination.
The decree updated on 07/08/2021 broadens the indications and specifies the new modalities of vaccination against COVID-19 to immunocompromised patients (by the disease or the necessary treatments: long term corticosteroids, immunosuppressive drugs, Rituximab or other biotherapies), marrow and organ transplant patients and some other diseases.
The latest recommendations of the SFGM-TC of 20/09/2021 specify the indications for a 3rd injection in patients over 65 years of age and in immunocompromised patients who have not developed antibodies, or even a 4th injection in some cases. This will depend on your response to the first two doses of vaccine. We therefore advise you to contact the secretariat of the hospital where you are being treated and your referring physician to be vaccinated according to the MATHEC recommendations. If you have already contracted COVID-19: in this case, you must wait at least 3 months after the onset of symptoms of COVID-19 to receive an injection.
Our mission
To further knowledge, improve clinical practice, patient care, and tranlational research into the clinical and biological follow-up of patients with autoimmune diseases treated with bone marrow transplant and other stem cell therapies in France.
The next MATHEC Friday meeting will take place on 29/10/2021 on "Mesenchymal Stem Cells and Autoimmune Disease Treatments".
To connect to the meeting: click here
Meeting ID: 939 0955 1146/ Secret code: 3E4Sce